PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm CEO steps down & Appointment of MD, page-15

  1. 539 Posts.
    lightbulb Created with Sketch. 59
    A lot of glass-half empty folk popping out today.

    Yes, it's very odd news and we would all like to know more, but Paul has got us here so far and nothing has changed with what we've got.
    It's all been good news lately with the trials in my book.

    Perhaps Paul has his eye on the bigger prize, with meeting longer term objectives, and I have no doubt he has the best interest for PAR and holders in mind.

    Spook it down and I'll have to just buy more...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.